Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights into foot and mouth disease virus
Scientists previously thought that FMDV evolution is mainly driven by mutations caused by small copying errors.
Study shows recombination is a major driver of FMDV evolution 

A study by the Pirbright Institute has revealed new insights into the evolution of foot and mouth disease virus (FMDV).

The research, published in PLOS Pathogens, found that different FMDV populations swap sections of genetic material at a far higher rate than previously thought. The information will help scientists understand how the frequency of these changes can shape virus evolution and cause new outbreaks.

Until now, scientists believed that FMDV evolution is mainly driven by mutations - caused by small copying errors that accumulate in the RNA genome of the virus when it replicates, known as substitutions. In this new study, however, researchers show that mutations caused by viral recombination events, where different FMD viruses infecting the same animal swap sections of their genome, occur almost as often as substitutions.

To show that these recombination events occur, the team injected African buffaloes with two similar FMDV strains, and then examined changes in regions of the genomes that code for proteins in the FMDV outer shell, called the capsid. The host immune system targets capsid proteins to control infection, but changes in those proteins can sometimes prevent the immune system from recognising the virus, allowing it to ‘escape’ and potentially cause a new outbreak.

Their study also revealed that levels of recombination were up to 40 times higher in the initial phase of infection compared to later on during the persistent phase, indicating that new variants of FMDV are most likely to be created soon after an animal becomes infected.

The results align with previous research by Pirbrgith that demonstrates persistently-infected African buffaloes are unlikely to generate new FMDV variations and cause new outbreaks. Researchers say this is important because African buffalo act as a reservoir for FMD, carrying the virus for years without presenting clinical signs.

“The number of recombination events we saw between the two viruses used in this research was surprising”, said Professor Bryan Charleston, Director of The Pirbright Institute. “This tells us that recombination is a major driver of FMDV evolution and understanding the mechanisms that determine how new strains are generated could help researchers analyse emerging FMD outbreaks in the field.”

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.